Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2021. Module: SNOMED CT core module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1202561014 | Bisoprolol fumarate + hydrochlorothiazide 5mg/6.25mg (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
1215462019 | Bisoprolol fumarate + hydrochlorothiazide 5mg/6.25mg | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
1478617014 | Bisoprolol fumarate+hydrochlorothiazide 5mg/6.25mg | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
2463828010 | Bisoprolol fumarate + hydrochlorothiazide 5mg/6.25mg tablet (product) | en | Fully specified name | Inactive | Only initial character case insensitive | SNOMED CT core module |
2470307013 | Bisoprolol fumarate+hydrochlorothiazide 5mg/6.25mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
3084720012 | Bisoprolol fumarate + hydrochlorothiazide 5mg/6.25mg tablet | en | Synonym | Inactive | Only initial character case insensitive | SNOMED CT core module |
3490418016 | Product containing bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3494220014 | Product containing bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3501615010 | Bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3569175013 | Product containing only bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg/1 each oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3569176014 | Product containing only bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg/1 each oral tablet (clinical drug) | en | Fully specified name | Inactive | Entire term case insensitive | SNOMED CT core module |
3677112012 | Bisoprolol 5 mg and hydrochlorothiazide 6.25 mg oral tablet | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
3677113019 | Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
3677114013 | Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
108313001000001110 | Bisoprolol fumarate 5 mg and hydrochlorothiazide 6.25 mg oral tablet | en | Synonym | Active | Only initial character case insensitive | SNOMED CT United Kingdom Edition module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol fumarate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Bisoprolol fumarate | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Bisoprolol fumarate + hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has manufactured dose form | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol and hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Bisoprolol | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has manufactured dose form | Conventional release oral tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product manufactured as oral dose form | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Bisoprolol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has basis of strength substance | Bisoprolol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 5 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has basis of strength substance | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator value | 6.25 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength numerator unit | milligram | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has presentation strength denominator unit | Tablet | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has unit of presentation | Tablet | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing bisoprolol and hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has precise active ingredient | Bisoprolol | false | Inferred relationship | Existential restriction modifier | 1 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Has precise active ingredient | Hydrochlorothiazide | false | Inferred relationship | Existential restriction modifier | 2 | |
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Count of base of active ingredient | 2 | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Is a | Product containing only bisoprolol and hydrochlorothiazide in oral dose form (medicinal product form) | false | Inferred relationship | Existential restriction modifier | ||
Product containing precisely bisoprolol 5 milligram and hydrochlorothiazide 6.25 milligram/1 each conventional release oral tablet | Plays role | Diuretic therapeutic role | false | Inferred relationship | Existential restriction modifier |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets